Related Experiment Video
Updated: Sep 15, 2025

Study of Protein Dynamics via Neutron Spin Echo Spectroscopy
Published on: April 13, 2022
A Kinetic Model of Antigen-Dependent IgG Oligomerization and Complement Binding
Jürgen Strasser1, Nikolaus Frischauf1, Lukas Schustereder1
1NASAN University of Applied Sciences Upper Austria 4020 Linz Austria.
A new kinetic model predicts immunoglobulin G (IgG) oligomer formation, crucial for immune responses and antibody therapies. This understanding aids in optimizing immunotherapies targeting the classical complement pathway (CCP).
Area of Science:
- Immunology
- Biophysics
- Biochemistry
Background:
- The classical complement pathway (CCP) is vital for immunity, activated by IgG antibody oligomers binding to pathogens or abnormal cells.
- IgG oligomers also mediate effector functions like antibody-dependent cellular cytotoxicity and phagocytosis via Fcγ receptors.
- Optimizing IgG-based therapies necessitates a deep understanding of IgG oligomerization dynamics.
Purpose of the Study:
- To develop a kinetic model predicting IgG oligomer formation.
- To characterize molecular interactions governing IgG oligomerization.
- To apply the model for predicting complement-mediated cell lysis.
Main Methods:
- Development of a kinetic model incorporating IgG concentration, antigen density, subclass, Fc mutants, and inhibitors.
- Characterization of molecular interactions using single molecule force spectroscopy and grating coupled interferometry.
- Fitting experimental data from high-speed atomic force microscopy to quantify kinetic and thermodynamic parameters.
Main Results:
- A predictive kinetic model for IgG oligomer formation was successfully developed.
- Key rate constants and thermodynamic parameters, including free energy changes, were quantified.
- The model accurately predicted complement-mediated lysis in liposomal vesicle assays.
Conclusions:
- The developed mechanistic framework provides insights into IgG oligomerization.
- This framework can optimize antibody engineering for improved immunotherapies.
- It also aids in pharmacokinetic/pharmacodynamic modeling for therapies utilizing the CCP.
More Related Videos
09:37Optimized Negative Staining: a High-throughput Protocol for Examining Small and Asymmetric Protein Structure by Electron Microscopy
Published on: August 15, 2014
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016
Related Concept Videos
Antibody Actions
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Complement System
Cooperative Allosteric Transitions
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...